AM J CLIN DERMATOL - American journal of clinical dermatology
Publications
- 2023
Assessment of Efficacy and Safety Outcomes Beyond Week 16 in Clinical Trials of Systemic Agents Used for the Treatment of Moderate to Severe Atopic Dermatitis in Combination with Topical Corticosteroids
Silverberg, J. I., Armstrong, A., Blauvelt, A. & Reich, K., 11.2023, In: AM J CLIN DERMATOL. 24, 6, p. 913-925 13 p.Research output: SCORING: Contribution to journal › SCORING: Review article › Research
Impact of Ruxolitinib Cream on Work Productivity and Activity Impairment and Associated Indirect Costs in Patients with Atopic Dermatitis: Pooled Results From Two Phase III Studies
Bloudek, L., Eichenfield, L. F., Silverberg, J. I., Joish, V. N., Lofland, J. H., Sun, K., Augustin, M., Migliaccio-Walle, K. & Sullivan, S. D., 01.2023, In: AM J CLIN DERMATOL. 24, 1, p. 109-117 9 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2022
Expert Perspectives on Key Parameters that Impact Interpretation of Randomized Clinical Trials in Moderate-to-Severe Atopic Dermatitis
Silverberg, J. I., Simpson, E. L., Armstrong, A. W., de Bruin-Weller, M. S., Irvine, A. D. & Reich, K., 01.2022, In: AM J CLIN DERMATOL. 23, 1, p. 1-11 11 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2021
Nail Psoriasis and Quality-of-Life Measurement in Clinical Trials: Call for the Use of Nail-Specific Instruments
Blome, C., Augustin, M. & Klein, T. M., 11.2021, In: AM J CLIN DERMATOL. 22, 6, p. 747-755 9 p.Research output: SCORING: Contribution to journal › SCORING: Review article › Research
- 2020
Maintenance of Response Through up to 4 Years of Continuous Guselkumab Treatment of Psoriasis in the VOYAGE 2 Phase 3 Study
Reich, K., Armstrong, A. W., Foley, P., Song, M., Miller, M., Shen, Y. K., You, Y., Han, C. & Gordon, K. B., 12.2020, In: AM J CLIN DERMATOL. 21, 6, p. 881-890 10 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2017
Efficacy and Safety of Switching to Ixekizumab in Etanercept Non-Responders. A Subanalysis from Two Phase III Randomized Clinical Trials in Moderate-to-Severe Plaque Psoriasis (UNCOVER-2 and -3)
Blauvelt, A., Papp, K. A., Griffiths, C. E. M., Puig, L., Weisman, J., Dutronc, Y., Kerr, L. F., Ilo, D., Mallbris, L. & Augustin, M., 04.2017, In: AM J CLIN DERMATOL. 18, 2, p. 273-280 8 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
- 2016
Quality of Life in Patients with Atopic Dermatitis: Disease Burden, Measurement, and Treatment Benefit
Blome, C., Radtke, M. A., Eissing, L. & Augustin, M., 04.2016, In: AM J CLIN DERMATOL. 17, 2, p. 163-169 7 p.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review